Search results
Is CRISPR Therapeutics a Millionaire Maker?
Motley Fool via Yahoo Finance· 5 days agoThe company also has other high-impact clinical programs in later stages of development which are intended to treat conditions like renal cell ...
Director Julie Smith Sells 27,280 Shares of Exelixis Inc (EXEL) By GuruFocus
Investing.com· 3 days agoFollowing this transaction, the insider now owns 5,445 shares of Exelixis Inc. Exelixis Inc is a...
Aster Insights, ORIEN to Present Research Abstracts at the 60th ASCO Annual Meeting
Valley City Times Record· 6 days agoAster Insights, the leading provider of scientific and clinical intelligence for oncology discovery, today announced the company and members of the Oncology Research Information Exchange Network ...
ASCO Meeting News Research News and Press Releases
Newswise· 4 days agoNewswise - ASCO Meeting News: ASCO Meeting News Page 1
Dr. Reddy's (RDY), Alvotech Unite for Prolia & Xgeva Biosimilar
Zacks via Yahoo Finance· 5 days agoDr. Reddy's (RDY) announces entering into a license and supply agreement with Alvotech to develop...
Rutgers Cancer Institute and RWJBarnabas Health Se | Newswise
Newswise· 4 days agoClinicians and scientists from Rutgers Cancer Institute and RWJBarnabas Health will lead sessions...
Tumor mutations may not predict response to immuno | Newswise
Newswise· 5 days agoMay 22, 2024 – The number of mutations in the DNA of cancerous tumors may not be an indicator of how...
Get Ready for ASCO 2024 Annual Meeting | Newswise
Newswise· 5 days agoASCO, the largest event in cancer research, is approaching on May 31st. This year's meeting promises to be particularly groundbreaking, with new findings a
Assetmark Inc. Boosts Stock Position in BeiGene, Ltd. (NASDAQ:BGNE)
ETF DAILY NEWS· 21 hours agoAssetmark Inc. boosted its holdings in shares of BeiGene, Ltd. (NASDAQ:BGNE – Free Report) by 13.4% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange ...
Tumor mutations may not predict response to immunotherapy, study finds
Medical Xpress· 4 days agoThe findings, published in Nature Cancer, upend long-held conventional wisdom and could lead to more effective ways of deciding which patients will benefit most from this type of treatment.